(Q36640370)

15 August 2017

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program (English)

1 reference

Diabetes Prevention Program Research Group

15 August 2017

10

object named as

Diabetes Prevention Program Research Group

1 reference

15 August 2017

Steven E Kahn

6

0 references

William C. Knowler

9

object named as

William C Knowler

1 reference

15 August 2017

7

Steven M Haffner

1 reference

15 August 2017

Richard R Rubin

1

1 reference

15 August 2017

Yong Ma

2

1 reference

15 August 2017

David G Marrero

3

1 reference

15 August 2017

Mark Peyrot

4

1 reference

15 August 2017

Elizabeth L Barrett-Connor

5

1 reference

15 August 2017

David W Price

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

10 December 2007

1 reference

15 August 2017

1 reference

15 August 2017

31

1 reference

15 August 2017

3

1 reference

15 August 2017

420-426

1 reference

Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Weight gain in the treatment of mood disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

The Diabetes Prevention Program (DPP): description of lifestyle intervention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Depressive symptomatology in obese adults with type II diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Type 2 Diabetes and Depressive Symptoms in Older Adults: a Population-based Study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

No increased incidence of diabetes in antidepressant users

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Type of antidepressant therapy and risk of type 2 diabetes in people with depression.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

The association of comorbid depression with mortality in patients with type 2 diabetes

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Independent factors associated with major depressive disorder in a national sample of individuals with diabetes.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

The Diabetes Prevention Program: recruitment methods and results

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2373986

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

20 September 2018

1 reference

12 December 2020

Association of depression and diabetes complications: a meta-analysis

1 reference

12 December 2020

Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes

1 reference

12 December 2020

Symptoms of depression in patients with type II diabetes mellitus

1 reference

12 December 2020

Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss

1 reference

12 December 2020

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

1 reference

12 December 2020

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

1 reference

12 December 2020

Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC07-1827

1 reference

15 August 2017

1 reference

15 August 2017

1 reference